Eton Pharmaceuticals (ETON) Total Liabilities (2017 - 2026)

Eton Pharmaceuticals has disclosed Total Liabilities across 10 years of filings, most recently posting $69.2 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 10.93% year-over-year to $69.2 million; the TTM figure through Jun 2026 stood at $69.2 million (down 10.93% YoY), while the FY2025 annual figure was $66.0 million, up 27.59% from the prior year.
• Total Liabilities came in at $69.2 million for Q2 2026 at Eton Pharmaceuticals, up from $66.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $81.4 million in Q3 2025 to a low of $9.8 million in Q2 2022.
• Average Total Liabilities over 5 years is $32.9 million, with a median of $16.3 million recorded in 2023.
• Year-over-year, Total Liabilities jumped 323.26% in 2025 and fell 10.93% in 2026.
• Over 5 years, Total Liabilities stood at $12.0 million in 2022, then surged by 36.07% to $16.3 million in 2023, then surged by 217.87% to $51.7 million in 2024, then increased by 27.59% to $66.0 million in 2025, then rose by 4.95% to $69.2 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $69.2 million in Q2 2026, $66.0 million in Q4 2025, and $81.4 million in Q3 2025.